Cancer BiologybioRxiv
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
K. Vaccaro, J. Allen, T. W. Whitfield…·K. Weiskopf
The paper identifies targeted therapies that enhance lung cancer vulnerability to macrophage attack when combined with anti-CD47 antibodies, showing synergy across multiple genetic mutations.
DOI 10.1172/jci169315